153 related articles for article (PubMed ID: 38276982)
1. Prediction of human epidermal growth factor receptor 2 (HER2) status in breast cancer by mammographic radiomics features and clinical characteristics: a multicenter study.
Deng Y; Lu Y; Li X; Zhu Y; Zhao Y; Ruan Z; Mei N; Yin B; Liu L
Eur Radiol; 2024 Jan; ():. PubMed ID: 38276982
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound radiomics-based nomogram to predict lymphovascular invasion in invasive breast cancer: a multicenter, retrospective study.
Du Y; Cai M; Zha H; Chen B; Gu J; Zhang M; Liu W; Liu X; Liu X; Zong M; Li C
Eur Radiol; 2024 Jan; 34(1):136-148. PubMed ID: 37518678
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
4. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
Zhou J; Tan H; Li W; Liu Z; Wu Y; Bai Y; Fu F; Jia X; Feng A; Liu H; Wang M
Acad Radiol; 2021 Oct; 28(10):1352-1360. PubMed ID: 32709582
[TBL] [Abstract][Full Text] [Related]
5. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
Zheng S; Yang Z; Du G; Zhang Y; Jiang C; Xu T; Li B; Wang D; Qiu Y; Lin D; Zhang X; Shen J
Eur Radiol; 2024 Feb; ():. PubMed ID: 38363315
[TBL] [Abstract][Full Text] [Related]
6. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.
Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L
J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035
[TBL] [Abstract][Full Text] [Related]
7. A CT-based radiomics nomogram for prediction of human epidermal growth factor receptor 2 status in patients with gastric cancer.
Li Y; Cheng Z; Gevaert O; He L; Huang Y; Chen X; Huang X; Wu X; Zhang W; Dong M; Huang J; Huang Y; Xia T; Liang C; Liu Z
Chin J Cancer Res; 2020 Feb; 32(1):62-71. PubMed ID: 32194306
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma.
Xu A; Chu X; Zhang S; Zheng J; Shi D; Lv S; Li F; Weng X
BMC Cancer; 2022 Aug; 22(1):872. PubMed ID: 35945526
[TBL] [Abstract][Full Text] [Related]
9. Intra- and peritumoral radiomics features based on multicenter automatic breast volume scanner for noninvasive and preoperative prediction of HER2 status in breast cancer: a model ensemble research.
Wang H; Chen W; Jiang S; Li T; Chen F; Lei J; Li R; Xi L; Guo S
Sci Rep; 2024 Feb; 14(1):5020. PubMed ID: 38424285
[TBL] [Abstract][Full Text] [Related]
10. Machine learning-based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results.
Yan M; Yao J; Zhang X; Xu D; Yang C
Cancer Med; 2024 Feb; 13(3):e6946. PubMed ID: 38234171
[TBL] [Abstract][Full Text] [Related]
11. MRI-Based Machine Learning Radiomics for Preoperative Assessment of Human Epidermal Growth Factor Receptor 2 Status in Urothelial Bladder Carcinoma.
Yu R; Cai L; Gong Y; Sun X; Li K; Cao Q; Yang X; Lu Q
J Magn Reson Imaging; 2024 Mar; ():. PubMed ID: 38456745
[TBL] [Abstract][Full Text] [Related]
12. Intra- and Peritumoral Radiomics Model Based on Early DCE-MRI for Preoperative Prediction of Molecular Subtypes in Invasive Ductal Breast Carcinoma: A Multitask Machine Learning Study.
Zhang S; Wang X; Yang Z; Zhu Y; Zhao N; Li Y; He J; Sun H; Xie Z
Front Oncol; 2022; 12():905551. PubMed ID: 35814460
[TBL] [Abstract][Full Text] [Related]
13. Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study.
Liu Y; Wang Y; Wang Y; Xie Y; Cui Y; Feng S; Yao M; Qiu B; Shen W; Chen D; Du G; Chen X; Liu Z; Li Z; Yang X; Liang C; Wu L
EClinicalMedicine; 2022 Oct; 52():101562. PubMed ID: 35928032
[TBL] [Abstract][Full Text] [Related]
14. The Emergence of the Potential Therapeutic Targets: Ultrasound-Based Radiomics in the Prediction of Human Epidermal Growth Factor Receptor 2-Low Breast Cancer.
Du Y; Li F; Zhang M; Pan J; Wu T; Zheng Y; Chen J; Yao M; Kuang Y; Wu R; Diao X
Acad Radiol; 2024 Feb; ():. PubMed ID: 38309977
[TBL] [Abstract][Full Text] [Related]
15. CT radiomics model for predicting the Ki-67 proliferation index of pure-solid non-small cell lung cancer: a multicenter study.
Liu F; Li Q; Xiang Z; Li X; Li F; Huang Y; Zeng Y; Lin H; Fang X; Yang Q
Front Oncol; 2023; 13():1175010. PubMed ID: 37706180
[TBL] [Abstract][Full Text] [Related]
16. MRI-based multiregional radiomics for preoperative prediction of tumor deposit and prognosis in resectable rectal cancer: a bicenter study.
Li H; Chen XL; Liu H; Liu YS; Li ZL; Pang MH; Pu H
Eur Radiol; 2023 Nov; 33(11):7561-7572. PubMed ID: 37160427
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced magnetic resonance imaging radiomics analysis based on intratumoral subregions for predicting luminal and nonluminal breast cancer.
Feng S; Yin J
Quant Imaging Med Surg; 2023 Oct; 13(10):6735-6749. PubMed ID: 37869317
[TBL] [Abstract][Full Text] [Related]
18. Clinical-radiomics nomogram for identifying HER2 status in patients with breast cancer: A multicenter study.
Fang C; Zhang J; Li J; Shang H; Li K; Jiao T; Yin D; Li F; Cui Y; Zeng Q
Front Oncol; 2022; 12():922185. PubMed ID: 36158700
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of an Ultrasound-Based Radiomics Nomogram for Identifying HER2 Status in Patients with Breast Carcinoma.
Guo Y; Wu J; Wang Y; Jin Y
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553137
[TBL] [Abstract][Full Text] [Related]
20. Optimal
Zuo Y; Liu Q; Li N; Li P; Zhang J; Song S
Front Oncol; 2023; 13():1173355. PubMed ID: 37223682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
